Pharmaceutical stocks fell the most miserable stocks
This article will discuss the answers to the questions about the stocks that have fallen the most, the stocks that are not rising, the stocks that are polarized, the stocks that have risen, and the stocks that have high dividends, and the stocks that have a high dividend.
The Worst Stocks to Fall in Pharma Stocks
One of the worst stocks to fall in pharma stocks is Mecon Bio (300439). As of the close of business on January 31, 2023, shares of Maycomb Bio (300439) were trading at $14.48, down 9.95%. In addition, shares of UW Genetics (300176) and MindBio (002932) were also down 17.27% and 16.69%, respectively.
The above information is for reference only, investment risk, decision-making needs to be cautious.
Pharma Stocks That Aren't Going Up
The following are some of the pharmaceutical stocks that have been underperforming recently:
__Baiyunshan (600332): the stock has been falling since Aug. 22, 2022, and still hasn't rebounded, with the stock price having fallen a total of 46.53 percent.
__PharmaTech (02350): The stock started falling on Aug. 10, 2022, and has yet to rebound, with the share price having fallen a cumulative 44.35 percent.
__Hengrui Medicine (600612): the stock began falling on August 20, 2022 and has yet to rebound, with the stock price having fallen a cumulative 41.43%.
__Zhi Fei Bio (300122): the stock began falling since August 18, 2022, and has yet to rebound, with the stock price having fallen a total of 39.16%.
__Myriad Healthcare (300760): the stock began falling on August 18, 2022 and has yet to rebound, with the stock price having fallen a cumulative 38.96%.
The pharmaceutical stocks listed above have underperformed recently, and investors should fully consider the risk factors when making investment decisions.
Pharmaceutical stocks polarized stocks
Pharmaceutical stocks polarized stocks:
1. Recovery class: This type of stock includes pharmaceutical commercial stocks and Chinese medicine stocks. Pharmaceutical commercial stocks are strong, while the performance of Chinese medicine stocks is relatively weak.
2. Innovative drugs: this type of stock is strong, especially the listed companies of innovative drugs, such as Fosun Pharmaceuticals, Lizhu Group, Changchun High-Tech, Kangtai Biologicals and so on.
3. Vaccines: the trend of these stocks is also relatively strong, such as Zhifei Biological, Wanbangda, Changhong Huayi, Shanhe Pharmaceutical Auxiliary, Tonghua Jinma, Southwest Synthesis, Tiantan Biological, Lan Biological, Haiwang Biological, Kewa Biological, Tianli High-tech, Jiaoda Angli, Tibet Pharmaceutical, Pharmaceutical Quasi-Shares, HaiChuang Pharmaceutical, Pharmaceutical Stone Science and Technology, Kanglong Hualicheng, and so on.
In addition, Xinhua Pharmaceutical, Hualan Bio, Kaisheng New Material, Kangtai Bio, Wantai Bio, Anke Bio, Golden Dragon Feather, to the pure and clean energy, Teyi Pharmaceutical 002727, People's Republic of China 600790 and other stocks also performed well. In a research report on the pharmaceutical industry, a number of pharmaceutical stocks were rated as medium-term concern stocks, including Hualan Bio 002007, Rheinland Bio 002144, Qianjin Pharmaceuticals 600479, Tonghua Golden Horse 000766, Healthy Yuan 600657, Harbin Pharmaceutical Group 600664, JiangZhong Pharmaceuticals 600750, ZhenDong Pharmaceuticals 603488, XinLiTai 002384, Pientzehuang 600436, Yunnan Baiyao 000538, Dong'a Gum 000423, Jiuzhitang 000969, Tianshili 600535, Laobai Gan Wine 600559 and so on.
Investment risk, decision-making needs to be careful, it is recommended that you consult a professional investment adviser before specific operations.
Pharmaceutical stocks soaring stocks
July 13, pharmaceutical stocks soared, Medici, Kangtai Medical, Aohua Endoscopy, Kangtai Medical, Aipeng Medical, Medici, Aohua Endoscopy, Aipeng Medical, Myriad Medical, Medicine Stone Technology, Medici, Kangtai Medical, Aohua Endoscopy, Myriad Medical, Medicine Stone Technology, Medici, Kangtai Medical, Aihua Endoscopy, Myriad Medical, Medicine Stone Technology, Medici West, Kangtai Medical, Epon Medical, Aohua Endoscopy, Myriad Medical, Medicine Stone Technology, Medici, Kangtai Medical stop, Medicine Stone Technology rose more than 17%, Epon Medical rose more than 15%, Heart Pulse Medical, Heart Pulse Medical rose more than 14%, Medici rose more than 13%, Zhaoyan New Drugs rose more than 12%, Steady Healthcare, Baicheng Pharmaceuticals rose more than 11%, Tiger Pharmaceuticals, Jindicic up more than 10%, Renfo Pharmaceuticals, Menowar, Kanglong Chemical, Jiuzhou Pharmaceuticals, Kelaiying rose more than 9%, innovative health care, Meditech Medical rose more than 8%, Shangrong Medical, Lanwei Medical rose more than 7%, UW Genetics, Mind Bio rose more than 6%.
The stocks that rose more than 6% **** there are 20, A shares total turnover of 124.048 billion shares, turnover of 155.492 billion yuan, the turnover rate of 2.17%.
Pharmaceutical stocks with high dividends at low prices
Pharmaceutical stocks with high dividends at low prices, for example:
______ Hengrui Medicine. ____ The company is the largest domestic anti-tumor drug research and development enterprise, with strong R & D strength in the field of oncology, and has formed a whole industry chain layout from R & D to marketing and sales.2022 Hengrui Medicine's dividend program is 10 to pay 2.5 yuan, the total amount of dividends is 6.105 billion yuan.
______ Changchun High-Tech. ____ The company is one of the leading growth hormone companies in China, with product indications covering a wide range of indications such as growth hormone deficiency in children, adolescents, adults, chronic diseases, and bone growth and granulation tissue formation associated with the need for healing in patients with stress ulcers such as burns, wounds, and bone fractures.The Changchun Gaoxin dividend program for 2022 is 10 to 10 yuan, with a total dividend of 4.629 billion yuan.
______ Aier Ophthalmology.
____ company is one of the largest ophthalmic medical institutions in China, as well as the world's largest ophthalmic medical beauty institutions, its ophthalmic medical equipment, medical technology are in the international leading level, for the world's refractive eye surgery in the field of the leading enterprises.2022 Aier ophthalmology dividend program is 10 to pay 6 yuan, the total amount of dividends for 4.563 billion yuan.
______Menian Health. ____ The company is one of the most large-scale chain of medical diagnostic service providers in China, providing a full range of comprehensive medical diagnostic services for people of all ages through a diversified service network that comprehensively covers public hospitals, community centers, high-end medical checkup clubs, and business exhibitions.The 2022 dividend program of Meinian Health is $10 to $1.6, and the total amount of dividend distribution is 3.469 billion yuan.
______ Lepu Medical. ____ The company is one of the earliest enterprises engaged in the research and development and production of cardiovascular interventional diagnostic and therapeutic devices in China, and its products cover three major fields, namely cardiovascular diagnostic and therapeutic devices and equipments, implantable medical devices, and in vitro diagnostic reagents and instruments.The dividend program of Lepu Medical for 2022 is RMB 10 to 2 yuan, and the total dividend distribution amounted to NT$3.439 billion.
The above are just some of the pharmaceutical stocks with high dividends at low prices, investors need to combine more data and information to assess the investment risk when choosing.
That's all for the introduction of the worst falling stocks in pharmaceutical stocks.